Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity (Q80918229)
Jump to navigation
Jump to search
scientific article published on 01 April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity |
scientific article published on 01 April 2008 |
Statements
Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity (English)
Keith Hamel
Paul Doodes
Yanxia Cao
Yumei Wang
Jeffrey Martinson
Robert Dunn
Marilyn R Kehry
Balint Farkas
Alison Finnegan